David Bonderman bought $6.5M of CeriBell (CBLL)
Executed Oct 15 2024, disclosed Oct 17 2024, 2 days later.
Over the 21 trading sessions from the disclosed entry session (Oct 17 2024), the stock returned +2.6% (delay-adjusted); from the execution session (Oct 15 2024), +13.8%. Derived: entry at the session's open, exit at the close 20 sessions later.
David Bonderman (10% owner) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in CeriBell, Inc. (CBLL). Across 1 priced purchase filing, the average 21-session return was +13.8% from execution and +2.6% from disclosure (delay-adjusted; derived). The largest single filing was $6.5M of CBLL (380,268 sh × $17.00, as filed), executed Oct 15 2024.
Healthcare · CeriBell, Inc. operates as a medical technology company in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→